Clavulanic Acid
Back to searchMolecule Structure
Scientific Name
Clavulanic Acid
Description of the Drug
Clavulanic acid is a beta lactamase inhibitor used to enhance the effectiveness of beta lactam antibiotics.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00766
http://www.drugbank.ca/drugs/DB00766
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Micro Labs Ltd India, Teva Pharmaceuticals Usa Inc, Wockhardt Bio Ag, Us Antibiotics Llc, Glaxosmithkline, Glaxosmithkline Intellectual Property No 2 Ltd England, Sandoz Inc, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial beta-lactamase TEM | SINGLE PROTEIN | INHIBITOR | CHEMBL2364670 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL6093 | ||
| PharmGKB | PA164742987 | ||
| Human Metabolome Database | HMDB0014904 | ||
| DrugBank | DB00766 | ||
| PubChem: Thomson Pharma | 15171670 | 15120937 | |
| PubChem | 5280980 | ||
| NMRShiftDB | 60072267 | ||
| Nikkaji | J14.640D | J1.018.185B | |
| PDBe | J01 | ||
| BindingDB | 50021959 | ||
| EPA CompTox Dashboard | DTXSID2022830 | ||
| DrugCentral | 669 | ||
| Metabolights | MTBLC48947 | ||
| Brenda | 1004 | 6886 | |
| ChemicalBook | CB9722501 | ||
| Guide to Pharmacology | 11128 | ||
| rxnorm | CLAVULANATE | CLAVULANIC ACID | CLAVULANATE POTASSIUM |
| KEGG Ligand | C06662 | ||
| ChEBI | 48947 | ||
| ZINC | ZINC000003830569 |
